Aptus Pharma share price
BSE: 544529Pharmaceuticals & BiotechnologySmall Cap
Aptus Pharma Limited · Face value ₹10 Face value. The nominal value of one share as the company issued it, the unit its share capital is counted in and a dividend can be stated as a percentage of; it has no link to the share price. Face value in the glossary · Listed Sep 2025
Last close ₹462.70down ₹9.40 (1.99%)
Share price at the BSE close on 28 Oct 2026. Previous close ₹472.10.
28 Oct: open ₹462.70, high ₹462.70, low ₹462.70
52-week range of traded prices to 28 Oct 2026
₹49.24Low, 3 Nov 2025₹510.90High, 23 Oct 2026
- Market capMarket capitalisation. Share price times the number of shares: what the whole company is worth at the day's price. The rank is by average market value over the six months to Jun 2026, among listed companies. Market capitalisation: how it is worked out
- ₹794 Cr2,265th largest listed
- P/EPrice to earnings, trailing. Market cap divided by the profit of the last twelve months (the latest four quarters, or two half years for a company that reports half-yearly) that belongs to the company's own shareholders, after the share of the other owners of its subsidiaries: what investors pay for each rupee of a year's profit. Price to earnings, trailing: how it is worked out
- 99.82
- P/BPrice to book. Market cap divided by the net worth that belongs to the company's own shareholders, its assets less everything it owes and less the other owners' share of its subsidiaries, on its latest balance sheet. Price to book: how it is worked out
- 27.92
- Dividend yieldDividend yield. Dividends paid per share in the twelve months to the day, as a percentage of the day's share price.
- Nonein the last 12 months
- ROEReturn on equity. Profit over the last twelve months (the latest four quarters, or two half years for a company that reports half-yearly) that belongs to the company's own shareholders, as a percentage of their net worth, the money they have in the business. Net worth is the average of the latest balance sheet and the one a year before it.
- 31.7%
- Debt to equityDebt to equity. Borrowings divided by the whole group's net worth, the other owners of its subsidiaries included: rupees borrowed for each rupee of equity in the business. Lease liabilities are not counted: the results filings do not state them. From the balance sheet at the end of Sep 2026.
- 0.43
- Volume, BSEVolume. Shares traded on the last trading day. Volume in the glossary
- 28,800
Results
Standalone; ₹ crore.Aptus Pharma half-yearly results
Half year to Sep 2026, against the half year before
- RevenueRevenue. The pill is the change in revenue against the half year before: this period's figure divided by that one's, less one, in per cent.
- ₹49 Crup 51.94%
- Net profitNet profit. The pill is the change in net profit against the half year before: this period's figure divided by that one's, less one, in per cent. Net profit in the glossary
- ₹5.08 Crup 76.69%
- Net marginNet margin. Net profit as a percentage of revenue: how much of each rupee of sales is left after every cost, interest and tax. Net margin in the glossary
- 10.4%
Revenue by half year
Peak revenue ₹49 Cr, half year to Sep 2026; lowest ₹14 Cr, half year to Sep 2025
Net profit by half year, a loss in red
| ₹ crore | Sep 2025 | Mar 2026 | Sep 2026 |
|---|---|---|---|
| Revenue | 14.4 | 32.2 | 48.9 |
| Net profit | 1.7 | 2.9 | 5.1 |
| Net margin | 12.1% | 8.9% | 10.4% |
Standalone. The 3 half years from Sep 2025, the first on record. The latest is shaded.
Year to Mar 2026
- Revenue
- ₹47 Cr
- Net profit
- ₹4.62 Cr
- Net margin
- 9.9%
| ₹ crore | Mar 2026 |
|---|---|
| Revenue | 46.6 |
| Net profit | 4.6 |
| Net margin | 9.9% |
Standalone. Years to March.
Business segments
In the year to Mar 2026 the company reports one business segment, Marketing and Distribution of finished pahrmaceutical formulations, which carries all its revenue.
Valuation
Today, against the company's own history. Dividend yield is not shown: no dividend in the years on record.Aptus Pharma PE ratio and valuation
Price to book
At or below today's level on 94% of 223 trading days since Nov 2025.
LowestHighest
Its median13.37Industry median2.94
Promoter and insider buying and selling
Trades made since 29 Oct 2025.Aptus Pharma insider trading
No promoter, director, key manager or employee bought or sold on the market.
- Promoters and promoter group: no market trade · 9 off-market moves
Bought and sold count trades on the market only. A pledge is shares given to a lender as security for a loan; a lender invokes it by selling them.
Aptus Pharma competitors and peers
Pharmaceuticals, 215 listed companies, priced on 28 Oct 2026. The table lists the 8 companies closest to Aptus Pharma in market cap.Healthcare companies
Where the company sits among the companies nearest its size
| Company | ||||||||
|---|---|---|---|---|---|---|---|---|
 Sigachi IndustriesSIGACHI | 1,014 | 40.00 | 1.94 | −9.6% | – | 4.5% | 4.3% | 0.38% |
 Themis MedicareTHEMISMED | 907 | 22.68 | 2.27 | −12.8% | – | 10.0% | −10.5% | 0.51% |
 Shree Ganesh RemediesSGRL | 845 | 54.73 | 5.18 | −8.8% | −29.4% | 10.0% | 10.6% | 0.00% |
 Anuh PharmaANUHPHR | 798 | 18.06 | 2.27 | +9.7% | −4.3% | 13.0% | 15.2% | 1.88% |
 Zim LaboratoriesZIMLAB | 758 | 205.08 | 2.56 | +7.6% | −60.6% | 1.3% | 1.8% | 0.00% |
 Kilitch Drugs (India)KILITCH | 752 | 25.01 | 2.69 | +14.0% | – | 12.5% | 8.9% | 0.00% |
 Valiant LaboratoriesVALIANTLAB | 683 | 42.70 | 2.20 | +89.6% | +12,324.8% | 5.9% | 7.0% | 0.00% |
 Influx HealthtechINFLUX | 625 | 30.41 | 6.20 | – | – | 20.4% | – | 0.00% |
Market cap in ₹ crore. Growth is the last twelve months against the twelve before. A figure is left empty where it would rest on a loss or the company has under a year of results on record. ROE is the shareholders' profit over their net worth. ROCE is profit before interest and tax over the whole group's net worth plus borrowings, as in the figures at the top of the page.
Latest announcements
Routine notices left out.Aptus Pharma announcements
Oct 2026
16 Oct · Board meeting
Meeting on 20 Oct 2026: half yearly results
Sep 2026
17 Sep · Analysts
Aptus Pharma share price by year
Each calendar year to 2025.Aptus Pharma share price history
| Year | Close at year end | Change | Highest close | Lowest close |
|---|---|---|---|---|
| 2025 | 67.80 | – | 67.94 | 33.20 |
₹ per share, adjusted for splits and bonuses since. Change is on the close at the end of the year before. 2025 is from its first session, 30 Sep 2025.
Recent sessions
The 9 trading days to 27 Oct 2026, as traded on BSE; the latest is at the top of the page.
| Date | Open | High | Low | Close | Average price | Volume |
|---|---|---|---|---|---|---|
| 27 Oct 2026 | 472.10 | 472.10 | 472.10 | 472.10 | 472.10 | 11,600 |
| 26 Oct 2026 | 481.70 | 481.70 | 481.70 | 481.70 | 481.70 | 10,400 |
| 23 Oct 2026 | 510.90 | 510.90 | 491.50 | 491.50 | 494.52 | 18,000 |
| 22 Oct 2026 | 496.00 | 501.50 | 496.00 | 501.50 | 500.96 | 13,600 |
| 21 Oct 2026 | 491.70 | 491.70 | 482.10 | 491.70 | 489.36 | 26,800 |
| 19 Oct 2026 | 482.10 | 482.10 | 482.10 | 482.10 | 482.10 | 11,200 |
| 16 Oct 2026 | 472.65 | 472.65 | 472.65 | 472.65 | 472.65 | 10,800 |
| 15 Oct 2026 | 463.40 | 463.40 | 463.00 | 463.40 | 463.39 | 12,800 |
| 14 Oct 2026 | 454.35 | 455.00 | 454.35 | 454.35 | 454.69 | 25,200 |
Prices in ₹ per share as traded, not adjusted.
Price adjustments
What the price chart is corrected for, so it reads as one share held throughout.Bonus share history
| Ex-date | Event | Price factor | What happened |
|---|---|---|---|
| 12 May 2026 | Bonus | 0.4000 | Holders received 3 bonus shares for every 2 held. |
Earlier prices are multiplied by the factor, so the chart reads as one share held throughout.
Company details
- BSE code
- 544529
- ISIN
- INE15XJ01010
- Industry
- Pharmaceuticals & Biotechnology
- Website
- www.aptus-pharma.com
- CIN
- U24230GJ2010PLC061957
- Corporate identity number, the registrar of companies' code for it
- Incorporated
- 2010
- Registered office
- Ashutosh Buildcon, Opp. Slok - 2, Nr. Harikrupa Logistic Park, Aslali, Daskroi, Ahmedabad 382427, Gujarat
- Share registrar
- Accurate Securities & Registry Pvt. Ltd
- Keeps the register of shareholders and handles transfers and dividend payments
In BSE SME IPO